Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jaguar Health Inc (NQ: JAGX ) 1.270 +0.090 (+7.63%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jaguar Health Inc < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Jaguar Health Reports Voting Results from 2021 Annual Meeting of Stockholders September 03, 2021 Proposals 1, 2, 4, 5 & 6 approved SAN FRANCISCO, CA / ACCESSWIRE / September 3, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Jaguar Health Subsidiary Napo Pharmaceuticals Submits Late-Breaking Abstract for Consideration for Presentation at the 2021 IDWeek Annual Meeting August 23, 2021 Exploratory study evaluating effects of crofelemer on gut microbiome SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2021 / Napo Pharmaceuticals, the wholly-owned subsidiary of Jaguar Health, Inc.... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Subsidiary Napo Pharmaceuticals Signs License Agreement with its Italian Subsidiary, Napo EU S.p.A., to Develop and Commercialize Crofelemer and Lechlemer in Europe August 19, 2021 Per the terms of the agreement, Napo Pharmaceuticals will receive an upfront payment of $10 million payable in two installments following the anticipated merger of Napo EU and Dragon SPAC S.p.A. and is... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Subsidiary Announces Completion of Additional Preclinical Study of Lechlemer (NP-300), the Company's Human Drug Product Candidate for Diarrhea Relief from Cholera and Other Acute Infectious Diarrhea August 17, 2021 In support of planned Investigational New Drug application for lechlemer, Napo Pharmaceuticals, Jaguar's wholly owned subsidiary, received comprehensive animal toxicity preclinical services supported... From Jaguar Health, Inc. Via AccessWire Topics Death Exposures Death Product Safety Thinking About Buying Stock In Alibaba, Coinbase Or Jaguar Health? July 07, 2021 One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... Via Benzinga Jaguar Animal Health (JAGX) Q2 2021 Earnings Call Transcript August 13, 2021 JAGX earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial 12 Health Care Stocks Moving In Friday's Pre-Market Session August 13, 2021 Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The company's market cap stands at $135.3 million. As per... Via Benzinga Jaguar Health, Inc. Reports 2021 Second Quarter Financial Results August 13, 2021 Second quarter 2021 Mytesi® net and gross sales were approximately $0.4 million and approximately $4.9 million Company transitioning to primarily selling Mytesi directly through selected specialty... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures COVID-19 Legal Product Safety Recap: Jaguar Health Q2 Earnings August 13, 2021 Shares of Jaguar Health (NASDAQ:JAGX) moved higher by 1.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 77.27%... Via Benzinga Earnings Scheduled For August 13, 2021 August 13, 2021 Companies Reporting Before The Bell • Jaguar Health (NASDAQ:JAGX) is expected to report quarterly loss at $0.03 per share on revenue of $7.28 million. • Fangdd... Via Benzinga The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO August 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety Jaguar Health Announces Time Change for Friday, August 13th Investor Webcast to 8:00 AM Eastern Time August 10, 2021 Registration link for webcast appears below Company plans to file Q2 2021 10-Q on August 13, 2021 SAN FRANCISCO, CA / ACCESSWIRE / August 10, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health to Host Investor Webcast Friday, August 13th at 8:30 AM Eastern Time Regarding Q2 2021 Financials & Business Updates August 10, 2021 - Registration link for webcast appears below - Company plans to file Q2 2021 10-Q on August 13, 2021 - Jaguar kicks off educational awareness contest in honor of African Traditional Medicine Day SAN... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, September 3, 2021 and Encourages All Shareholders to Vote August 06, 2021 Based on a preliminary review of votes cast, over 75% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene September 3, 2021 at 8:30 AM Pacific Standard Time to provide time to... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory REMINDER FROM JAGUAR HEALTH: Innovators with Jane King Interview with Lisa Conte to Air During Jaguar Investor Webcast on Thursday, July 29, 2021 at 8:30 AM Eastern to Provide Business Updates July 28, 2021 Registration link for webcast appears below SAN FRANCISCO, CA / ACCESSWIRE / July 28, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) issued a reminder today that an Innovators with Jane King interview of... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Announces that Innovators with Jane King Interview with Lisa Conte will Air During Jaguar Investor Webcast on Thursday, July 29, 2021 at 8:30 AM Eastern to Provide Business Updates July 26, 2021 Registration link for webcast appears below SAN FRANCISCO, CA / ACCESSWIRE / July 26, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) announced today that an Innovators with Jane King interview of Lisa Conte,... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 23, 2021 SAN FRANCISCO, CA / ACCESSWIRE / July 23, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ('Jaguar' or the 'Company') announced today that effective July 15, 2021, the Company granted nonstatutory stock... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety 24 Stocks Moving in Tuesday's Pre-Market Session July 20, 2021 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 36.9% to $3.86 in pre-market trading after gaining more than 3% on Monday. SuperCom Ltd. (NASDAQ: SPCB) shares... Via Benzinga Napo EU S.p.A., Jaguar Health's Italian Subsidiary, and Dragon SPAC S.p.A. Announce Close of 8,830,000 Euro Dragon SPAC Financing July 19, 2021 Napo EU, the identified target of Dragon SPAC, seeks to develop plant-based crofelemer to potentially treat orphan disease - short bowel syndrome (crofelemer has received orphan-drug designation from... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Announces Completion of Investigator-Initiated Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer Patients July 14, 2021 Abstract of study results submitted by the third-party investigators to December 2021 San Antonio Breast Cancer Symposium SAN FRANCISCO, CA / ACCESSWIRE / July 14, 2021 / Jaguar Health, Inc.... From Jaguar Health, Inc. Via AccessWire Exposures Product Safety Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, August 6, 2021 and Encourages All Shareholders to Vote July 09, 2021 Based on a preliminary review of votes cast, over 74% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene August 6, 2021 at 8:30 AM Pacific Standard Time to provide time to... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory 31 Stocks Moving in Thursday's Pre-Market Session July 08, 2021 Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares rose 46% to $8.41 in pre-market trading after the company reported strong preliminary results for its first quarter... Via Benzinga JAGX Stock: The New Analyst Price Target Making Jaguar Health Jump Today July 07, 2021 Jaguar Health (JAGX) stock is jumping higher on Wednesday after an analyst initiated coverage of the shares with a positive rating. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021 July 07, 2021 Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 07, 2021 Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $... Via Benzinga Jaguar Health Set to Join Russell Microcap Index June 23, 2021 Jaguar kicks off educational awareness contest about medicinal plants SAN FRANCISCO, CA / ACCESSWIRE / June 23, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that... From Jaguar Health, Inc. Via AccessWire Topics Derivatives Exposures Derivatives Product Safety 12 Health Care Stocks Moving In Wednesday's After-Market Session June 16, 2021 Gainers Satsuma Pharmaceuticals (NASDAQ:STSA Via Benzinga Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, July 9, 2021 and Encourages All Shareholders to Vote June 11, 2021 Based on a preliminary review of votes cast, over 76% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene July 9, 2021 at 8:30 AM Pacific Standard Time to provide time to reach... From Jaguar Health, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory 24 Stocks Moving in Thursday's Pre-Market Session June 10, 2021 Gainers Medley Management Inc. (NASDAQ: MDLY) rose 144.9% to $14.30 in pre-market trading after gaining 9% on Wednesday. Medley LLC recently received NYSE notice regarding... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session June 09, 2021 Gainers Enzo Biochem (NYSE:ENZ) stock increa... Via Benzinga < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.